These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 16294265)

  • 41. Cloning and characterization of osteoclast precursors from the RAW264.7 cell line.
    Cuetara BL; Crotti TN; O'Donoghue AJ; McHugh KP
    In Vitro Cell Dev Biol Anim; 2006; 42(7):182-8. PubMed ID: 16948499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of luteolin on osteoclast differentiation, function in vitro and ovariectomy-induced bone loss.
    Kim TH; Jung JW; Ha BG; Hong JM; Park EK; Kim HJ; Kim SY
    J Nutr Biochem; 2011 Jan; 22(1):8-15. PubMed ID: 20233653
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of ormeloxifene on ovariectomy-induced bone resorption, osteoclast differentiation and apoptosis and TGF beta-3 expression.
    Narayana Murthy PS; Sengupta S; Sharma S; Singh MM
    J Steroid Biochem Mol Biol; 2006 Aug; 100(4-5):117-28. PubMed ID: 16797179
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Conditional deletion of E11/Podoplanin in bone protects against ovariectomy-induced increases in osteoclast formation and activity.
    Staines KA; Hopkinson M; Dillon S; Stephen LA; Fleming R; Sophocleous A; Buttle DJ; Pitsillides AA; Farquharson C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31894854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency.
    Kanematsu M; Sato T; Takai H; Watanabe K; Ikeda K; Yamada Y
    J Bone Miner Res; 2000 Jul; 15(7):1321-9. PubMed ID: 10893680
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Unoccupied alpha(v)beta3 integrin regulates osteoclast apoptosis by transmitting a positive death signal.
    Zhao H; Ross FP; Teitelbaum SL
    Mol Endocrinol; 2005 Mar; 19(3):771-80. PubMed ID: 15591537
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of basic fibroblast growth factor on osteoclasts and osteoclast-like cells.
    Zuo J; Jiang J; Dolce C; Holliday LS
    Biochem Biophys Res Commun; 2004 May; 318(1):162-7. PubMed ID: 15110768
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune interactions with CD4+ T cells promote the development of functional osteoclasts from murine CD11c+ dendritic cells.
    Alnaeeli M; Penninger JM; Teng YT
    J Immunol; 2006 Sep; 177(5):3314-26. PubMed ID: 16920972
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dynamic changes in the osteoclast cytoskeleton in response to growth factors and cell attachment are controlled by beta3 integrin.
    Faccio R; Novack DV; Zallone A; Ross FP; Teitelbaum SL
    J Cell Biol; 2003 Aug; 162(3):499-509. PubMed ID: 12900398
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Macrophage colony-stimulating factor and receptor activator NF-kappaB ligand fail to rescue osteoclast-poor human malignant infantile osteopetrosis in vitro.
    Flanagan AM; Massey HM; Wilson C; Vellodi A; Horton MA; Steward CG
    Bone; 2002 Jan; 30(1):85-90. PubMed ID: 11792569
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of
    Kim M; Kim JH; Hong S; Kwon B; Kim EY; Jung HS; Sohn Y
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184080
    [TBL] [Abstract][Full Text] [Related]  

  • 52. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
    Valverde P; Tu Q; Chen J
    J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Phloretin promotes osteoclast apoptosis in murine macrophages and inhibits estrogen deficiency-induced osteoporosis in mice.
    Lee EJ; Kim JL; Kim YH; Kang MK; Gong JH; Kang YH
    Phytomedicine; 2014 Sep; 21(10):1208-15. PubMed ID: 24932975
    [TBL] [Abstract][Full Text] [Related]  

  • 54. TRAF2 is essential for TNF-alpha-induced osteoclastogenesis.
    Kanazawa K; Kudo A
    J Bone Miner Res; 2005 May; 20(5):840-7. PubMed ID: 15824857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
    Blin-Wakkach C; Breuil V; Quincey D; Bagnis C; Carle GF
    Bone; 2006 Jul; 39(1):53-60. PubMed ID: 16503212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Shark protein improves bone mineral density in ovariectomized rats and inhibits osteoclast differentiation.
    Uehara K; Takahashi A; Watanabe M; Nomura Y
    Nutrition; 2014 Jun; 30(6):719-25. PubMed ID: 24800672
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DICAM inhibits osteoclast differentiation through attenuation of the integrin αVβ3 pathway.
    Jung YK; Han SW; Kim GW; Jeong JH; Kim HJ; Choi JY
    J Bone Miner Res; 2012 Sep; 27(9):2024-34. PubMed ID: 22492581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Osteoactivin is a novel osteoclastic protein and plays a key role in osteoclast differentiation and activity.
    Sheng MH; Wergedal JE; Mohan S; Lau KH
    FEBS Lett; 2008 Apr; 582(10):1451-8. PubMed ID: 18381073
    [TBL] [Abstract][Full Text] [Related]  

  • 59.
    Kim JH; Shin H; Kim M; Kim S; Song K; Jung HS; Sohn Y
    Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184079
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.
    Sampath TK; Simic P; Sendak R; Draca N; Bowe AE; O'Brien S; Schiavi SC; McPherson JM; Vukicevic S
    J Bone Miner Res; 2007 Jun; 22(6):849-59. PubMed ID: 17352644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.